星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2024-02-28 ms5000001373452742 来自福建省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2020-11-21 luancdc

审稿速度:6.0 | 投稿命中率:50.0
经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，

157 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2023-02-07 1484b4c3m87暂无昵称来自江苏省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：免疫治疗
经验分享：11月10号提交，2月7号接受，审稿人没有太为难

62 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2022-11-26 ms3000001074290381 来自上海

请问提交文稿后怎么撤回呢？

68 0

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2022-01-20 口口口

两个月没有消息是要被拒了吗？

71 0

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2021-12-27 衣谷

一般期刊要求几张图/几个表？

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2021-12-27 rayms

如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2015-07-29 xn8008

审稿速度:2.0 | 投稿命中率:25.0
经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！

492 0

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2015-02-02 weixu532

审稿速度:3.0 | 投稿命中率:50.0
经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低

507 0

[GetPortalCommentsPageByObjectIdResponse(id=2190005, encodeId=b09b2190005ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：辣鸡期刊，两个审稿人根本没看我写的是啥，提的问题根本不是我文章的重点，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ac96481760, createdName=ms5000001373452742, createdTime=Wed Feb 28 23:44:37 CST 2024, time=2024-02-28, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=901006, encodeId=3ccc901006f3, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：效率很高的杂志，编辑很nice。但对文章质量要求较高，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=075c1625649, createdName=luancdc, createdTime=Sat Nov 21 16:48:13 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113525, encodeId=ab8a2113525f8, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：免疫治疗 经验分享：11月10号提交，2月7号接受，审稿人没有太为难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=238c5283805, createdName=1484b4c3m87暂无昵称, createdTime=Tue Feb 07 20:10:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2102806, encodeId=825b210280625, content=请问提交文稿后怎么撤回呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62168276083, createdName=ms3000001074290381, createdTime=Sat Nov 26 20:37:03 CST 2022, time=2022-11-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1186451, encodeId=d2d3118645199, content=两个月没有消息是要被拒了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5285577911, createdName=口口口, createdTime=Thu Jan 20 14:34:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105307, encodeId=7cd2110530ee3, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105308, encodeId=08e111053088c, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514009, encodeId=d5db514009a4, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：我投稿的时间比较波折，开始是杂志改名字，原来叫Human Vaccine，后来在后面加了个Immunotherapeutics，我开始没当回事，审稿的速度是第一次审查38天，提出一些问题，修了一下，第二稿审查速度是26天，而且没提出什么问题，之后本来很高兴得到通知说被录用了，说是被录取到2014年第12期了，可是过了将近一个月也没动静，接下来就是发现他们出版商改了，当时我们这个懵啊，不知道杂志还存在不，可喜的是2015年底收到他们新编辑部编辑的通知，要我交版面费，等等一堆，不过还好，一切顺利，付了费用，他们很快给我邮件，可以下载全文了，我老师也特别高兴。不过我提醒大家，投这杂志需要好好修修你的英语，要不然他们会对你的文章里面不是内容，而是写作水平发飙的哦！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=492, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b721636481, createdName=xn8008, createdTime=Wed Jul 29 20:17:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509520, encodeId=d1075095209c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：悲剧了！审稿太慢了，3个月过去了，还是under reviewer，看来是赶不上5月份答辩了。。。。效率太低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=507, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=562943058, createdName=weixu532, createdTime=Mon Feb 02 11:35:00 CST 2015, time=2015-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509423, encodeId=4390509423b4, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b1e21611668, createdName=131198cfe9m, createdTime=Wed Jan 28 22:06:00 CST 2015, time=2015-01-28, status=1, ipAttribution=)]

2015-01-28 131198cfe9m

审稿速度:6.0 | 投稿命中率:25.0
经验分享：疫苗方面专业杂志，2013年的IF为3.643，杂志更名前为Human Vaccines,审稿较慢，特别是一审，从投稿到接受总共将近一年的时间，中间小修了2次。着急毕业的，建议不要投此杂志。而且此杂志稿源也特别多，也不太容易中，我们实验室投了3篇，就中了我这一篇，可能是我的文章润色的原因吧。美国本土杂志，英语写作水平要求特别高。版面费也不低噢

422 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务